These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 3059738
1. Hereditary pituitary prolactinomas: a new rat model. Chedid A, Hoversland RC, Chejfec G, McCune SA, Jurin RR, Evans EE. Acta Endocrinol (Copenh); 1988 Dec; 119(4):535-42. PubMed ID: 3059738 [Abstract] [Full Text] [Related]
2. Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link? Perić B, Kruljac I, Šundalić S, Pećina HI, Jović A, Štefanović M, Butorac D, Vrkljan M. Endocr Res; 2016 Aug; 41(3):200-6. PubMed ID: 26864960 [Abstract] [Full Text] [Related]
3. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas. Ma W, Ikeda H, Yoshimoto T. Cancer; 2002 Jul 15; 95(2):258-66. PubMed ID: 12124824 [Abstract] [Full Text] [Related]
4. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas. Talan-Hranilović J, Gnjidić Z, Sajko T, Vizner B, Vrkljan M. Acta Med Croatica; 2000 Jul 15; 54(2):59-63. PubMed ID: 11028110 [Abstract] [Full Text] [Related]
5. Correlations between presence of spontaneous lesions of the pituitary (adenohypophysis) and plasma prolactin concentration in aged Wistar rats. van Nesselrooij JH, Kuper CF, Bosland MC. Vet Pathol; 1992 Jul 15; 29(4):288-300. PubMed ID: 1325082 [Abstract] [Full Text] [Related]
6. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat]. Gao L, Yang QH, Xu RK. Sheng Li Xue Bao; 2005 Jun 25; 57(3):319-27. PubMed ID: 15968426 [Abstract] [Full Text] [Related]
7. Women with prolactin-producing pituitary adenoma show decreased serum placental lactogen during pregnancy. Luthman M, Bremme K, Eneroth P, Werner S. Gynecol Obstet Invest; 1993 Jun 25; 35(2):80-5. PubMed ID: 8449449 [Abstract] [Full Text] [Related]
8. Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Carretero J, Burks DJ, Vázquez G, Rubio M, Hernández E, Bodego P, Vázquez R. Pituitary; 2002 Jan 25; 5(1):5-10. PubMed ID: 12638719 [Abstract] [Full Text] [Related]
9. Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels. Ahtiainen P, Sharp V, Rulli SB, Rivero-Müller A, Mamaeva V, Röyttä M, Huhtaniemi I. Endocr Relat Cancer; 2010 Sep 25; 17(3):611-21. PubMed ID: 20453081 [Abstract] [Full Text] [Related]
10. Pituitary adenomas in old Sprague-Dawley rats: a histologic, ultrastructural, and immunocytochemical study. McComb DJ, Kovacs K, Beri J, Zak F. J Natl Cancer Inst; 1984 Nov 25; 73(5):1143-66. PubMed ID: 6092768 [Abstract] [Full Text] [Related]
11. [Analysis of different mutations in regulatory sequence of prolactin gene during the formation of 17 beta-estradiol-induced prolactinoma in eutopic and ectopic pituitary of rats]. Zhang FZ, Yang QH, Mao YC, Xu RK. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec 25; 28(6):822-7. PubMed ID: 17260475 [Abstract] [Full Text] [Related]
12. Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine. Osamura RY, Watanabe K. Acta Pathol Jpn; 1986 Aug 25; 36(8):1131-7. PubMed ID: 3776530 [Abstract] [Full Text] [Related]
13. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture. Yamaji T, Ishibashi M, Teramoto A, Fukushima T. Acta Endocrinol (Copenh); 1985 Apr 25; 108(4):456-63. PubMed ID: 2859725 [Abstract] [Full Text] [Related]
14. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes. Cristina C, Díaz-Torga GS, Goya RG, Kakar SS, Perez-Millán MI, Passos VQ, Giannella-Neto D, Bronstein MD, Becu-Villalobos D. Mol Cancer; 2007 Jan 12; 6():4. PubMed ID: 17222350 [Abstract] [Full Text] [Related]
15. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules. Saitoh Y, Koizumi K, Arita N, Hayakawa T, Mogami H, Matsumoto K, Mori H. Anticancer Res; 1986 Jan 12; 6(5):1149-55. PubMed ID: 3800323 [Abstract] [Full Text] [Related]
17. Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models. Cao L, Gao H, Gui S, Bai G, Lu R, Wang F, Zhang Y. J Neurooncol; 2014 Feb 12; 116(3):523-31. PubMed ID: 24407733 [Abstract] [Full Text] [Related]
18. Expression and clinical significance of miR-193a-3p in invasive pituitary adenomas. Su WJ, Wang JS, Ye MD, Chen WL, Liao CX. Eur Rev Med Pharmacol Sci; 2020 Jul 12; 24(14):7673-7680. PubMed ID: 32744693 [Abstract] [Full Text] [Related]
19. [Morphological studies on estrogen-induced PRL cell hyperplasia in rat pituitary gland--immunocytochemical and scanning electron microscopic studies]. Inagaki H, Hori T. No To Shinkei; 1989 Jun 12; 41(6):593-601. PubMed ID: 2803826 [Abstract] [Full Text] [Related]
20. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors. Ishibashi M, Yamaji T, Takaku F, Teramoto A, Fukushima T. J Clin Endocrinol Metab; 1987 Jun 12; 64(6):1187-93. PubMed ID: 2437140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]